Margarida Maia, PhD, science writer —

Margarida is a biochemist (University of Porto, Portugal) with a PhD in biomedical sciences (VIB and KULeuven, Belgium). Her main interest is science communication. She is also passionate about design and the dialogue between art and science.

Articles by Margarida Maia

First COPD Patient Enrolled in Phase 4 Study of Yupelri vs. Spiriva

A first patient has been enrolled in a Phase 4 study of the effectiveness of Yupelri (revefenacin) against Spiriva (tiotropium) in improving lung health in adults with severe chronic obstructive pulmonary disease (COPD). The respective safety of these two approved, once-daily COPD maintenance treatments will also be evaluated. Yupelri, developed…

Anti-inflammatory Compound MgIG Eases COPD Symptoms in Rat Model

An anti-inflammatory compound used in China to help treat liver disease — known as magnesium isoglycyrrhizinate (MgIG) — eased the symptoms of chronic obstructive pulmonary disease (COPD) by reducing inflammation in the lungs, a study in a rat disease model reported. “These findings suggest MgIG might be an alternative for…

Simple, Low-cost Tests May Help Identify Undiagnosed COPD in China

Low-cost screening involving a questionnaire and a breathing test may help identify patients with undiagnosed chronic obstructive pulmonary disease (COPD), a study conducted in China has found. Among the combinations tested, the Chinese symptom-based questionnaire (C-SBQ) combined with microspirometry — a test that measures how much air a patient…

Hemoglobin May Be Promising Biomarker of Clinical Outcomes

Hemoglobin, the protein that carries oxygen in blood, may be a promising biomarker to assess the clinical outcomes of patients with chronic obstructive pulmonary disease (COPD), a large U.S.-based study has found. The findings indicate that unusually high or low levels of hemoglobin were linked to worse clinical outcomes.